메뉴 건너뛰기




Volumn 50, Issue 5, 2007, Pages 361-368

Prediction of response to pegylated interferon and ribavirin in hepatitis C by polymorphisms in the viral core protein and very early dynamics of viremia

Author keywords

Chronic hepatitis; HCV core; Hepatitis C virus; Pegylated interferon; Ribavirin; Virological responses

Indexed keywords

CORE PROTEIN; PEGINTERFERON ALPHA2B; RIBAVIRIN;

EID: 35549000195     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107707     Document Type: Article
Times cited : (52)

References (38)
  • 1
    • 0032583933 scopus 로고    scopus 로고
    • Hepatitis C
    • Di Bisceglie AM: Hepatitis C. Lancet 1998;351:351-355.
    • (1998) Lancet , vol.351 , pp. 351-355
    • Di Bisceglie, A.M.1
  • 3
    • 0022444885 scopus 로고
    • Interferon in viral hepatitis: Role in pathogenesis and treatment
    • Davis GL, Hoofnagle JH: Interferon in viral hepatitis: role in pathogenesis and treatment. Hepatology 1986;6:1038-1041.
    • (1986) Hepatology , vol.6 , pp. 1038-1041
    • Davis, G.L.1    Hoofnagle, J.H.2
  • 9
    • 4444232174 scopus 로고    scopus 로고
    • Predictors of response to therapy for chronic hepatitis C
    • Ferenci P: Predictors of response to therapy for chronic hepatitis C. Semin Liver Dis 2004;24:S25-S31.
    • (2004) Semin Liver Dis , vol.24
    • Ferenci, P.1
  • 10
    • 1442308277 scopus 로고    scopus 로고
    • Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: Who responds less well?
    • Zeuzem S: Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: who responds less well? Ann Intern Med 2004;140:370-381.
    • (2004) Ann Intern Med , vol.140 , pp. 370-381
    • Zeuzem, S.1
  • 12
    • 0041822106 scopus 로고    scopus 로고
    • Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C
    • Davis GL, Wong JB, McHutchison JG, Manns MP, Harvey J, Albrecht J: Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C. Hepatology 2003;38:645-652.
    • (2003) Hepatology , vol.38 , pp. 645-652
    • Davis, G.L.1    Wong, J.B.2    McHutchison, J.G.3    Manns, M.P.4    Harvey, J.5    Albrecht, J.6
  • 15
    • 33846593397 scopus 로고    scopus 로고
    • Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: Amino acid substitutions in the core region and low-density lipoprotein cholesterol levels
    • Akuta N, Suzuki F, Kawamura Y, Yatsuji H, Sezaki H, Suzuki Y, Hosaka T, Kobayashi M, Kobayashi M, Arase Y, Ikeda K, Kumada H: Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: amino acid substitutions in the core region and low-density lipoprotein cholesterol levels. J Hepatol 2007;46:403-410.
    • (2007) J Hepatol , vol.46 , pp. 403-410
    • Akuta, N.1    Suzuki, F.2    Kawamura, Y.3    Yatsuji, H.4    Sezaki, H.5    Suzuki, Y.6    Hosaka, T.7    Kobayashi, M.8    Kobayashi, M.9    Arase, Y.10    Ikeda, K.11    Kumada, H.12
  • 17
    • 33847036713 scopus 로고    scopus 로고
    • A nucleotide sequence variation detection system for the core region of hepatitis C virus-1b
    • Okamoto K, Akuta N, Kumada H, Kobayashi M, Matsuo Y, Tazawa H: A nucleotide sequence variation detection system for the core region of hepatitis C virus-1b. J Virol Methods 2007;141:1-6.
    • (2007) J Virol Methods , vol.141 , pp. 1-6
    • Okamoto, K.1    Akuta, N.2    Kumada, H.3    Kobayashi, M.4    Matsuo, Y.5    Tazawa, H.6
  • 18
    • 0036830567 scopus 로고    scopus 로고
    • Monitoring of viral levels during therapy of hepatitis C
    • Davis GL: Monitoring of viral levels during therapy of hepatitis C. Hepatology 2002;36:S145-S151.
    • (2002) Hepatology , vol.36
    • Davis, G.L.1
  • 21
    • 0032940812 scopus 로고    scopus 로고
    • Early prediction of response in interferon monotherapy and in interferon-ribavirin combination therapy for chronic hepatitis C: HCV RNA at 4 weeks versus ALT
    • Brouwer JT, Hansen BE, Niesters HG, Schalm SW: Early prediction of response in interferon monotherapy and in interferon-ribavirin combination therapy for chronic hepatitis C: HCV RNA at 4 weeks versus ALT. J Hepatol 1999;30:192-198.
    • (1999) J Hepatol , vol.30 , pp. 192-198
    • Brouwer, J.T.1    Hansen, B.E.2    Niesters, H.G.3    Schalm, S.W.4
  • 22
    • 0031924165 scopus 로고    scopus 로고
    • Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa
    • Zeuzem S, Lee JH, Franke A, Ruster B, Prummer O, Herrmann G, Roth WK: Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa. Hepatology 1998;27:1149-1156.
    • (1998) Hepatology , vol.27 , pp. 1149-1156
    • Zeuzem, S.1    Lee, J.H.2    Franke, A.3    Ruster, B.4    Prummer, O.5    Herrmann, G.6    Roth, W.K.7
  • 23
    • 0034102575 scopus 로고    scopus 로고
    • Natural history of hepatitis C and the impact of anti-viral therapy
    • Boyer N, Marcellin P: Natural history of hepatitis C and the impact of anti-viral therapy. Forum (Genova) 2000;10:4-18.
    • (2000) Forum (Genova) , vol.10 , pp. 4-18
    • Boyer, N.1    Marcellin, P.2
  • 25
    • 0036380991 scopus 로고    scopus 로고
    • First phase viral kinetic parameters as predictors of treatment response and their influence on the second phase viral decline
    • Layden JE, Layden TJ, Reddy KR, Levy-Drummer RS, Poulakos J, Neumann AU: First phase viral kinetic parameters as predictors of treatment response and their influence on the second phase viral decline. J Viral Hepat 2002;9:340-345.
    • (2002) J Viral Hepat , vol.9 , pp. 340-345
    • Layden, J.E.1    Layden, T.J.2    Reddy, K.R.3    Levy-Drummer, R.S.4    Poulakos, J.5    Neumann, A.U.6
  • 27
    • 0030039045 scopus 로고    scopus 로고
    • Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo
    • Zeuzem S, Schmidt JM, Lee JH, Ruster B, Roth WK: Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo. Hepatology 1996;23:366-371.
    • (1996) Hepatology , vol.23 , pp. 366-371
    • Zeuzem, S.1    Schmidt, J.M.2    Lee, J.H.3    Ruster, B.4    Roth, W.K.5
  • 28
    • 0036378151 scopus 로고    scopus 로고
    • First-phase parameters in hepatitis C viral kinetics
    • Zeuzem S, Herrmann E: First-phase parameters in hepatitis C viral kinetics. J Viral Hepat 2002;9:332-333.
    • (2002) J Viral Hepat , vol.9 , pp. 332-333
    • Zeuzem, S.1    Herrmann, E.2
  • 29
    • 9644254247 scopus 로고    scopus 로고
    • Early viral kinetics and treatment outcome in combination of high-dose interferon induction vs. pegylated interferon plus ribavirin for naive patients infected with hepatitis C virus of genotype 1b and high viral load
    • Tsubota A, Arase Y, Someya T, Suzuki Y, Suzuki F, Saitoh S, Ikeda K, Akuta N, Hosaka T, Kobayashi M, Kumada H: Early viral kinetics and treatment outcome in combination of high-dose interferon induction vs. pegylated interferon plus ribavirin for naive patients infected with hepatitis C virus of genotype 1b and high viral load. J Med Virol 2005;75:27-34.
    • (2005) J Med Virol , vol.75 , pp. 27-34
    • Tsubota, A.1    Arase, Y.2    Someya, T.3    Suzuki, Y.4    Suzuki, F.5    Saitoh, S.6    Ikeda, K.7    Akuta, N.8    Hosaka, T.9    Kobayashi, M.10    Kumada, H.11
  • 33
    • 0036829856 scopus 로고    scopus 로고
    • Hepatocellular carcinoma and hepatitis C in the United States
    • El-Serag HB: Hepatocellular carcinoma and hepatitis C in the United States. Hepatology 2002;36:S74-S83.
    • (2002) Hepatology , vol.36
    • El-Serag, H.B.1
  • 34
    • 24944439884 scopus 로고    scopus 로고
    • National prevention of hepatocellular carcinoma in Japan based on epidemiology of hepatitis C virus infection in the general population
    • Yoshizawa H, Tanaka J, Miyakawa Y: National prevention of hepatocellular carcinoma in Japan based on epidemiology of hepatitis C virus infection in the general population. Intervirology 2006;49:7-17.
    • (2006) Intervirology , vol.49 , pp. 7-17
    • Yoshizawa, H.1    Tanaka, J.2    Miyakawa, Y.3
  • 35
    • 0036595049 scopus 로고    scopus 로고
    • Suppressors of cytokine signalling (SOCS) in the immune system
    • Alexander WS: Suppressors of cytokine signalling (SOCS) in the immune system. Nat Rev Immunol 2002;2:410-416.
    • (2002) Nat Rev Immunol , vol.2 , pp. 410-416
    • Alexander, W.S.1
  • 38
    • 11144342298 scopus 로고    scopus 로고
    • Hepatitis C virus core protein down-regulates transcription of interferon-induced antiviral genes
    • De Lucas S, Bartolome J, Carreno V: Hepatitis C virus core protein down-regulates transcription of interferon-induced antiviral genes. J Infect Dis 2005;191:93-99.
    • (2005) J Infect Dis , vol.191 , pp. 93-99
    • De Lucas, S.1    Bartolome, J.2    Carreno, V.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.